Pheophorbide a-mediated photodynamic therapy triggers HLA class I-restricted antigen presentation in human hepatocellular carcinoma

Translational Oncology

Volumn 3, Issue 2, 2010, Pages 114-122

  Tang, Patrick Ming Kuen ^a,b   Bui Xuan, Ngoc Ha ^a   Wong, Chun Kwok ^a,c   Fong, Wing Ping ^a   Fung, Kwok Pui ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYTOCHROME C; DISULFIDE; HEAT SHOCK PROTEIN 70; HLA ANTIGEN CLASS 1; ISOMERASE; PHEOPHORBIDE; PHEOPHORBIDE A; PHOSPHATIDYLSERINE; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL STRAIN HEPG2; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CROSS PRESENTATION; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOPRECIPITATION; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER MITOCHONDRION; PHOTODYNAMIC THERAPY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEOMICS; TUMOR IMMUNITY; WESTERN BLOTTING;

EID: 77953369306     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.09262     Document Type: Article

References (41)

1. Harrod-Kim P (2006). Tumor ablation with photodynamic therapy: introduction to mechanism and clinical applications. J Vasc Interv Radiol 17, 1441-1448.
2. Ackroyd R, Kelty C, Brown N, and Reed M (2001). The history of photodetection and photodynamic therapy. Photochem Photobiol 74, 656-669.
3. Daniell MD and Hill JS (1991). A history of photodynamic therapy. Aust N Z J Surg 61, 340-348.
4. Zhu TC and Finlay JC (2008). The role of photodynamic therapy (PDT) physics. Med Phys 35, 3127-3136.
5. Vogelstein B and Kinzler KW (2004). Cancer genes and the pathways they control. Nat Med 10, 789-799.
6. + T cells and dependent on natural killer cells. Br J Cancer 96, 1839-1848.
7. Kousis PC, Henderson BW, Maier PG, and Gollnick SO (2007). Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils. Cancer Res 67, 10501-10510.
8. Krosl G, Korbelik M, and Dougherty GJ (1995). Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy. Br J Cancer 71, 549-555.
9. Takamiya KI, Tsuchiya T, and Ohta H (2000). Degradation pathway(s) of chlorophyll: what has gene cloning revealed? Trends Plant Sci 5, 426-431.
10. Chan JY, Tang PM, Hon PM, Au SW, Tsui SK, Waye MM, Kong SK, Mak TC, and Fung KP (2006). Pheophorbide a, a major antitumor component purified from Scutellaria barbata, induces apoptosis in human hepatocellular carcinoma cells. Planta Med 72, 28-33.
11. Oonsivilai R, Cheng C, Bomser J, Ferruzzi MG, and Ningsanond S (2007). Phytochemical profiling and phase II enzyme-inducing properties of Thunbergia laurifolia Lindl. (RC) extracts. J Ethnopharmacol 114, 300-306.
12. Chee CF, Lee HB, Ong HC, and Ho AS (2005). Photocytotoxic pheophorbide-related compounds from Aglaonema simplex. Chem Biodivers 2, 1648-1655.
13. Lee WY, Lim DS, Ko SH, Park YJ, Ryu KS, Ahn MY, Kim YR, Lee DW, and Cho CW (2004). Photoactivation of pheophorbide a induces a mitochondrial-mediated apoptosis in Jurkat leukaemia cells. J Photochem Photobiol B 75, 119-126.
14. Hajri A, Wack S, Meyer C, Smith MK, Leberquier C, Kedinger M, and Aprahamian M (2002). In vitro and in vivo efficacy of photofrin and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells. Photochem Photobiol 75, 140-148.
15. Jin ZH, Miyoshi N, Ishiguro K, Umemura S, Kawabata K, Yumita N, Sakata I, Takaoka K, Udagawa T, Nakajima S, et al. (2000). Combination effect of photodynamic and sonodynamic therapy on experimental skin squamous cell carcinoma in C3H/HeN mice. J Dermatol 27, 294-306.
16. Hajri A, Coffy S, Vallat F, Evrard S, Marescaux J, and Aprahamian M (1999). Human pancreatic carcinoma cells are sensitive to photodynamic therapy in vitro and in vivo. Br J Surg 86, 899-906.
17. Tang PM, Liu XZ, Zhang DM, Fong WP, and Fung KP (2009). Pheophorbide a based photodynamic therapy induces apoptosis via mitochondrial-mediated pathway in human uterine carcinosarcoma. Cancer Biol Ther 8, 49-55.
18. Tang PM, Chan JY, Au SW, Kong SK, Tsui SK, Waye MM, Mak TC, Fong WP, and Fung KP (2006). Pheophorbide a, an active compound isolated from Scutellaria barbata, possesses photodynamic activities by inducing apoptosis in human hepatocellular carcinoma. Cancer Biol Ther 5, 1111-1116.
19. Tang PM, Zhang DM, Xuan NH, Tsui SK, Waye MM, Kong SK, Fong WP, and Fung KP (2009). Photodynamic therapy inhibits P-glycoprotein mediated multidrug resistance via JNK activation in human hepatocellular carcinoma using the photosensitizer pheophorbide a. Mol Cancer 8, 56.
20. Yamashita Y, Moriyasu F, Ono S, Kimura T, Kajimura K, Someda H, Hamato N, Nabeshima M, Sakai M, and Okuma M (1991). Photodynamic therapy using pheophorbide-a and Q-switched Nd:YAG laser on implanted human hepatocellular carcinoma. Gastroenterol Jpn 26, 623-627.
21. Qiang YG, Yow CM, and Huang Z (2008). Combination of photodynamic therapy and immunomodulation: current status and future trends. Med Res Rev 28, 632-644.
22. Zhang DM, Wang Y, Tang MK, Chan YW, Lam HM, Ye WC, and Fung KP (2007). Saxifragifolin B from Androsace umbellata induced apoptosis on human hepatoma cells. Biochem Biophys Res Commun 362, 759-765.
23. Tang PM, Chan JY, Zhang DM, Au SW, Fong WP, Kong SK, Tsui SK, Waye MM, Mak TC, and Fung KP (2007). Pheophorbide a, an active component in Scutellaria barbata, reverses P-glycoprotein-mediated multidrug resistance on a human hepatoma cell line R-HepG2. Cancer Biol Ther 6, 504-509.
24. Cho SY, Park PJ, Shin ES, Lee JH, Chang HK, and Lee TR (2009). Proteomic analysis of mitochondrial proteins of basal and lipolytically (isoproterenol and TNF-alpha)-stimulated adipocytes. J Cell Biochem 106, 257-266.
25. Lee SK, Wong CK, Poon PM, Ip PS, Che CT, Fung KP, Leung PC, and Lam CW (2006). In vitro immunomodulatory activities of a newly concocted traditional Chinese medicine formula: VI-28. Phytother Res 20, 883-888.
26. Campoli M and Ferrone S (2008). HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance. Oncogene 27, 5869-5885.
27. Fabris C, Valduga G, Miotto G, Borsetto L, Jori G, Garbisa S, and Reddi E (2001). Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis and necrosis. Cancer Res 61, 7495-7500.
28. Hsu CY, Chen YH, Chao PY, Chen CM, Hsieh LL, and Hu SP (2008). Naturally occurring chlorophyll derivatives inhibit aflatoxin B1-DNA adduct formation in hepatoma cells. Mutat Res 657, 98-104.
29. Evrard S, Keller P, Hajri A, Balboni G, Mendoza-Burgos L, Damge C, Marescaux J, and Aprahamina M (1994). Experimental pancreatic cancer in the rat treated by photodynamic therapy. Br J Surg 81, 1185-1189.
30. Castano AP, Mroz P, and Hamblin MR (2006). Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 6, 535-545.
31. Korbelik M (1996). Induction of tumor immunity by photodynamic therapy. J Clin Laser Med Surg 14, 329-334.
32. van Duijnhoven FH, Aalbers RI, Rovers JP, Terpstra OT, and Kuppen PJ (2003). The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiology 207, 105-113.
33. Canti G, De Simone A, and Korbelik M (2002). Photodynamic therapy and the immune system in experimental oncology. Photochem Photobiol Sci 1, 79-80.
34. Ren W, Strube R, Zhang X, Chen SY, and Huang XF (2004). Potent tumor-specific immunity induced by an in vivo heat shock protein-suicide gene-based tumor vaccine. Cancer Res 64, 6645-6651.
35. Korbelik M, Sun J, and Cecic I (2005). Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Res 65, 1018-1026.
36. Dick TP (2004). Assembly of MHC class I peptide complexes from the perspective of disulfide bond formation. Cell Mol Life Sci 61, 547-556.
37. Cresswell P, Arunachalam B, Bangia N, Dick T, Diedrich G, Hughes E, and Maric M (1999). Thiol oxidation and reduction in MHC-restricted antigen processing and presentation. Immunol Res 19, 191-200.
38. Castellino F, Boucher PE, Eichelberg K, Mayhew M, Rothman JE, Houghton AN, and Germain RN (2000). Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J Exp Med 191, 1957-1964.
39. Bendz H, Ruhland SC, Pandya MJ, Hainzl O, Riegelsberger S, Braüchle C, Mayer MP, Buchner J, Issels RD, and Noessner E (2007). Human heat shock protein 70 enhances tumor antigen presentation through complex formation and intracellular antigen delivery without innate immune signaling. J Biol Chem 282, 31688-31702.
40. Korbelik M, Stott B, and Sun J (2007). Photodynamic therapy-generated vaccines: relevance of tumour cell death expression. Br J Cancer 97, 1381-1387.
41. Korbelik M and Krosl G (1994). Enhanced macrophage cytotoxicity against tumor cells treated with photodynamic therapy. Photochem Photobiol 60, 497-502.